<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>X80243</GBSeq_locus>
    <GBSeq_length>537</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>VRL</GBSeq_division>
    <GBSeq_update-date>28-MAY-1996</GBSeq_update-date>
    <GBSeq_create-date>06-SEP-1994</GBSeq_create-date>
    <GBSeq_definition>Human T-cell leukemia virus type II (patient Bo) gp21 gene</GBSeq_definition>
    <GBSeq_primary-accession>X80243</GBSeq_primary-accession>
    <GBSeq_accession-version>X80243.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>emb|X80243.1|</GBSeqid>
      <GBSeqid>gi|577063</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>transmembrane glycoprotein gp21</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Human T-lymphotropic virus 2</GBSeq_source>
    <GBSeq_organism>Human T-lymphotropic virus 2</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes; Ortervirales; Retroviridae; Orthoretrovirinae; Deltaretrovirus</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..537</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Salemi,M.</GBAuthor>
          <GBAuthor>Cattaneo,E.</GBAuthor>
          <GBAuthor>Casoli,C.</GBAuthor>
          <GBAuthor>Bertazzoni,U.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Identification of IIa and IIb molecular subtypes of Human T-cell lymphotropic virus type II among Italian injecting drug users</GBReference_title>
        <GBReference_journal>J. Acquir. Immune Defic. Syndr. 8, 516-520 (1995)</GBReference_journal>
      </GBReference>
      <GBReference>
        <GBReference_reference>2</GBReference_reference>
        <GBReference_position>1..537</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Salemi,M.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Direct Submission</GBReference_title>
        <GBReference_journal>Submitted (02-SEP-1994) M. Salemi, Istituto di Genetica Biochimica ed, Evoluzionistica del CNR, Via Abbiategrasso 207, 287100 Pavia, ITALY</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>On Nov 28, 1994 this sequence version replaced gi:535918.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..537</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>537</GBInterval_to>
            <GBInterval_accession>X80243.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Human T-lymphotropic virus 2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>genomic DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>strain</GBQualifier_name>
            <GBQualifier_value>HTLV-IIb</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>isolate</GBQualifier_name>
            <GBQualifier_value>patient Bo</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:11909</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>cell_type</GBQualifier_name>
            <GBQualifier_value>peripheral blood lymphocytes</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>dev_stage</GBQualifier_name>
            <GBQualifier_value>HTLV-II seropositive</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>gene</GBFeature_key>
        <GBFeature_location>1..534</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>534</GBInterval_to>
            <GBInterval_accession>X80243.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>gp21</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>mat_peptide</GBFeature_key>
        <GBFeature_location>1..534</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>534</GBInterval_to>
            <GBInterval_accession>X80243.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>gp21</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>product</GBQualifier_name>
            <GBQualifier_value>GP21 glycoprotein</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>gccgttccaatagcagtgtggcttgtctccgccctagcggccggaacaggtatcgctggtggagtaacaggctccctatctctggcttccagtaaaagccttctcctcgaggttgacaaagacatctcccaccttacccaggccatagtcaaaaatcatcaagacatcctccgggttgcacagtatgcagcccaaaatagacgaggattagacctcctattctgggaacaagggggtttgtgcaaggccatacaggaacaatgttgcttcctcaatatcagtaacactcatgtatccgtcctccaggaacggccccctcttgaaaaacgtgtcatcaccggctggggactaaactgggatcttggactgtcccaatgggcacgagaagccctccagacaggcataaccattctcgctctactcctcctcgtcatattgtttggcccctgtatcctccgccaaatccaggcccttccacagcggttacaaaaccgacataaccagtattcccttatcaacccagaaaccatgctataa</GBSeq_sequence>
  </GBSeq>
